Image

Microvascular Ocular Changes of Systemic Lupus Erythematous

Microvascular Ocular Changes of Systemic Lupus Erythematous

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

The goal of this observational study is to to assess the ocular microvascular status of SLE patients with inactive disease and without ocular involvement. The main questions it aims to answer are:

  • the choroidal vascular status and thickness in SLE
  • the retinal macular microvascular status and structure in SLE

Participants will be assessed with Spectral Domain Optical Coherence Tomography (SD-OCT). Researchers will compare SLE patients with healthy controls matched for age and sex.

Description

The investigators will perform a cross-sectional evaluation of 25 SLE patients and 25 healthy controls matched for sex and age, using a Spectral Domain Optical Coherence Tomography (SD-OCT) with Enhanced Depth Imaging for choroidal assessment and with Angiography module to assess the retinal and choriocapillaris vasculature. Processing of image with external software will be performed to calculate the main outcomes: retinal vessel density, foveal avascular zone parameters and the choroidal vascular index.

Eligibility

Systemic inclusion criteria for SLE patients:

  • fulfill the 2019 European League Against Rheumatism (EULAR) / American College of Rheumatology (ACR) classification criteria for the diagnosis of SLE
  • age between 18 and 80 years
  • no disease activity (SLEDAI <3)
  • no risk factors for drug toxicity

Systemic inclusion criteria for control group:

  • no systemic diseases
  • age between 18 and 80 years

Systemic exclusion criteria:

  • arterial hypertension (defined as systolic blood pressure higher than 140 mm Hg or diastolic blood pressure higher than 90 mm Hg) or medically treatment for hypertension
  • diabetes mellitus
  • nephropathy or other documented microvascular complications
  • secondary Sjögren syndrome
  • local or systemic inflammatory diseases (other than SLE)
  • smokers of more than 20 cigarettes a day
  • pregnancy.

Ophthalmological inclusion criteria:

  • best-corrected visual acuity ≤ 0.3 LogMAR
  • intra-ocular pressure <21 mm Hg on diurnal testing with measurements using Goldmann applanation tonometry
  • spherical equivalent refractive error between -6.0 and +4.0 diopters
  • open anterior chamber angle on slit lamp examination.

Ophthalmic exclusion criteria:

  • established primary ocular diseases including a history of any retinal or optic nerve disease
  • presence of significant lens opacities (Lens Opacities Classification System III equal to or more stage 2)
  • retinopathy
  • high refractive error
  • ocular hypertension
  • previous intraocular surgery or trauma.

Study details
    Eye Manifestations
    Lupus Erythematosus
    Systemic

NCT05863689

Universidade do Porto

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.